UPDATED Apr 21, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MOH | US$367.52 | 1.8% | 29.6% | US$21.5b | US$418.19 | PE19.7x | E14.7% | n/a | ||
PGNY | US$32.70 | -3.3% | -5.3% | US$3.1b | US$46.90 | PE50.7x | E22.9% | n/a | ||
PRVA | US$18.08 | -1.5% | -31.5% | US$2.1b | US$27.41 | PE93x | E26.4% | n/a | ||
ASTH | US$37.22 | -4.9% | -0.9% | US$1.8b | US$54.00 | PE29.6x | E17.3% | n/a | ||
VMD | US$7.88 | -3.2% | -32.0% | US$305.4m | US$13.84 | PE29.8x | E36.1% | n/a |